-+ 0.00%
-+ 0.00%
-+ 0.00%

Ecolab (ECL) Valuation Check After 12% Dividend Hike and 34th Straight Annual Increase

Simply Wall St·12/15/2025 18:17:32
Listen to the news

Ecolab (ECL) just extended its long dividend growth streak by approving a 12% increase to its quarterly payout, and that kind of steady cash return tends to catch long term investors’ attention.

See our latest analysis for Ecolab.

The latest move comes with the share price around $263.6 and supported by a solid year to date, with a 14.15% share price return and a three year total shareholder return of 92.24%, suggesting ongoing bullish momentum rather than signs of fatigue.

If Ecolab’s combination of growth and dividends has your attention, this could be a good moment to explore healthcare stocks as potential complementary ideas in your portfolio.

Yet with Ecolab trading just below analyst targets after a powerful multi year run, investors must weigh its dependable dividend and earnings growth against a rich valuation. Is there still upside left, or is future expansion already priced in?

Most Popular Narrative Narrative: 9.6% Undervalued

With Ecolab last closing at $263.60 against a narrative fair value of about $291.75, the current setup leans toward upside if assumptions hold.

The analysts have a consensus price target of $286.1 for Ecolab based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $325.0, and the most bearish reporting a price target of $243.0.

Read the complete narrative.

Curious how mid single digit growth, rising margins, and a rich future earnings multiple still point to upside from here? Unpack the full narrative to see why.

Result: Fair Value of $291.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, softer industrial demand and persistent macro uncertainty around tariffs and specialty chemicals volumes could pressure margins and challenge the upbeat earnings trajectory.

Find out about the key risks to this Ecolab narrative.

Another Way To Look At Value

On earnings, the picture looks tougher. Ecolab trades on a P E of about 37.6 times, well above the US chemicals industry at roughly 24 times and our fair ratio of 25.3 times. This suggests meaningful downside risk if sentiment cools before earnings catch up.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:ECL PE Ratio as at Dec 2025
NYSE:ECL PE Ratio as at Dec 2025

Build Your Own Ecolab Narrative

If you see the numbers differently or want to dive into the assumptions yourself, you can build a complete view in just a few minutes: Do it your way.

A great starting point for your Ecolab research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.

Ready for your next investing move?

Before you move on, seize this chance to strengthen your watchlist with focused ideas from the Simply Wall Street Screener tailored to different growth and income priorities.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.